NEFL and amyotrophic lateral sclerosis: Given their potential as biomarkers for ALS, considerable efforts have recently been made in the development of precise and reliable detection techniques for both NF-L and the phosphorylated form of NF-H (for review, see Poesen and Van Damme, 2018).